STOCK TITAN

MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

MultiPlan (NYSE: MPLN) has appointed Tiffani Misencik as Chief Growth Officer in a newly created executive leadership role. Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments, leading client acquisition, client management, and market expansion efforts. She will play a critical role in integrating revenue-related and organizational functions to drive sustainable and profitable growth.

Misencik brings over 25 years of experience in healthcare technology, previously serving as Chief Revenue Officer at Greenway Health and holding various sales leadership positions at Interlad and Allscripts. Her appointment is expected to support MultiPlan's vision of providing affordable healthcare for all and aligns with the company's growth objectives.

MultiPlan (NYSE: MPLN) ha nominato Tiffani Misencik come Chief Growth Officer in un nuovo ruolo di leadership esecutiva. Misencik supervisionerà la strategia di crescita delle vendite e dei ricavi di MultiPlan in tutti i segmenti di mercato, guidando l'acquisizione e la gestione dei clienti, nonché gli sforzi di espansione del mercato. Giocherà un ruolo fondamentale nell'integrare le funzioni relative ai ricavi e organizzative per favorire una crescita sostenibile e redditizia.

Misencik porta con sé oltre 25 anni di esperienza nella tecnologia sanitaria, avendo precedentemente ricoperto il ruolo di Chief Revenue Officer presso Greenway Health e detenuto varie posizioni di leadership nelle vendite presso Interlad e Allscripts. La sua nomina è prevista per supportare la visione di MultiPlan di fornire assistenza sanitaria accessibile a tutti e si allinea con gli obiettivi di crescita dell'azienda.

MultiPlan (NYSE: MPLN) ha nombrado a Tiffani Misencik como Chief Growth Officer en un nuevo rol de liderazgo ejecutivo. Misencik supervisará la estrategia de crecimiento de ventas e ingresos de MultiPlan en todos los segmentos de mercado, liderando la adquisición y gestión de clientes, así como los esfuerzos de expansión de mercado. Desempeñará un papel crítico en la integración de funciones relacionadas con los ingresos y organizativas para impulsar un crecimiento sostenible y rentable.

Misencik aporta más de 25 años de experiencia en tecnología de salud, habiendo ocupado anteriormente el cargo de Chief Revenue Officer en Greenway Health y distintos roles de liderazgo en ventas en Interlad y Allscripts. Se espera que su nombramiento apoye la visión de MultiPlan de proporcionar atención médica asequible para todos y se alinee con los objetivos de crecimiento de la empresa.

MultiPlan (NYSE: MPLN)는 Tiffani Misencik을 새로운 임원 리더십 역할인 Chief Growth Officer로 임명했습니다. Misencik은 모든 시장 부문에서 MultiPlan의 판매 및 수익 성장 전략을 감독하며, 고객 유치, 고객 관리, 시장 확장 노력을 이끌 것입니다. 그녀는 수익 관련 및 조직 기능을 통합하여 지속 가능하고 수익성 있는 성장을 주도하는 중요한 역할을 할 것입니다.

Misencik은 25년 이상의 경험을 보유하고 있으며, 이전에는 Greenway Health의 Chief Revenue Officer로 재직했고, Interlad와 Allscripts에서 여러 영업 리더십 직책을 맡았습니다. 그녀의 임명은 모두를 위한 저렴한 의료 서비스를 제공하려는 MultiPlan의 비전을 지원할 것으로 예상되며, 회사의 성장 목표와 일치합니다.

MultiPlan (NYSE: MPLN) a nommé Tiffani Misencik en tant que Chief Growth Officer dans un nouveau rôle de leadership exécutif. Misencik supervisera la stratégie de croissance des ventes et des revenus de MultiPlan dans tous les segments de marché, en dirigeant l'acquisition de clients, la gestion des clients et les efforts d'expansion du marché. Elle jouera un rôle essentiel dans l'intégration des fonctions liées aux revenus et organisationnelles pour favoriser une croissance durable et rentable.

Misencik possède plus de 25 ans d'expérience dans la technologie de la santé, ayant précédemment occupé le poste de Chief Revenue Officer chez Greenway Health et ayant occupé divers postes de direction dans les ventes chez Interlad et Allscripts. Son nomination devrait soutenir la vision de MultiPlan de fournir des soins de santé abordables pour tous et s'aligne sur les objectifs de croissance de l'entreprise.

MultiPlan (NYSE: MPLN) hat Tiffani Misencik zur Chief Growth Officer in einer neu geschaffenen Führungsposition ernannt. Misencik wird die Verkaufs- und Umsatzwachstumsstrategie von MultiPlan in allen Marktsegmenten überwachen und die Kundenakquise, Kundenmanagement sowie die Marktexpansion leiten. Sie wird eine entscheidende Rolle bei der Integration der umsatzbezogenen und organisatorischen Funktionen spielen, um nachhaltiges und profitables Wachstum voranzutreiben.

Misencik bringt über 25 Jahre Erfahrung in der Gesundheitstechnologie mit, nachdem sie zuvor als Chief Revenue Officer bei Greenway Health tätig war und verschiedene Vertriebsführungspositionen bei Interlad und Allscripts innehatte. Ihre Ernennung wird voraussichtlich die Vision von MultiPlan unterstützen, allen eine bezahlbare Gesundheitsversorgung zu bieten, und fügt sich gut in die Wachstumsziele des Unternehmens ein.

Positive
  • Appointment of experienced Chief Growth Officer to drive strategic growth
  • New executive role focused on sales and revenue growth strategy
  • Integration of revenue-related and organizational functions for sustainable growth
  • Addition of 25+ years of healthcare technology experience to the leadership team
Negative
  • None.

Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role

NEW YORK--(BUSINESS WIRE)-- MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company’s strategic growth.

Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan’s sales and revenue growth strategy across all market segments. She will lead the company’s efforts in client acquisition, client management, and market expansion. Misencik will play a critical leadership role in the integration and alignment between all revenue-related and organizational functions to drive sustainable and profitable growth.

“Tiffani’s addition to the MultiPlan leadership team strongly positions the Company to scale and operate a cohesive strategy that aligns with our growth objectives while building on the incredible work by our sales team,” said Travis Dalton, President and Chief Executive Officer of MultiPlan. “I look forward to Tiffani’s contributions to MultiPlan. Her experience will bring new perspective to our current business strategy that supports MultiPlan’s vision of providing affordable healthcare for all.”

Misencik is a C-Suite executive with more than 25 years of experience in healthcare technology. Prior to joining MultiPlan, she served as the Chief Revenue Officer at Greenway Health where she oversaw all revenue-generating activities, including sales, operations, marketing, and customer success. Prior to that, Misencik was the Vice President of Sales in North America for Interlad and also spent 17 years serving the hospital, health system, and ambulatory markets in various sales leadership positions at Allscripts. As an industry leader, she has a proven track record in creating significant revenue growth through new client acquisition and by expanding established client relationships. Misencik was recognized as Becker’s Top Women in Health 2024 and Women We Admire’s Top 50 Women Leaders in Technology 2024.

About MultiPlan

MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of-pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.

Investor Relations

Jason Wong

SVP, Treasury & Investor Relations

MultiPlan

866-909-7427

investor@multiplan.com



Shawna Gasik

AVP, Investor Relations

MultiPlan

866-909-7427

investor@multiplan.com



Media Relations

Pamela Walker

AVP, Marketing & Communications

MultiPlan

781-895-3118

Press@multiplan.com

Source: MultiPlan Corporation

FAQ

Who is the new Chief Growth Officer at MultiPlan (MPLN)?

Tiffani Misencik has been appointed as the new Chief Growth Officer at MultiPlan (NYSE: MPLN).

What are Tiffani Misencik's responsibilities as Chief Growth Officer at MultiPlan (MPLN)?

As Chief Growth Officer, Tiffani Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments, leading client acquisition, client management, and market expansion efforts.

What is Tiffani Misencik's professional background before joining MultiPlan (MPLN)?

Tiffani Misencik has over 25 years of experience in healthcare technology, previously serving as Chief Revenue Officer at Greenway Health and holding sales leadership positions at Interlad and Allscripts.

How does Tiffani Misencik's appointment align with MultiPlan's (MPLN) objectives?

Tiffani Misencik's appointment aligns with MultiPlan's growth objectives and supports the company's vision of providing affordable healthcare for all by bringing new perspectives to their current business strategy.

MultiPlan Corporation

NYSE:MPLN

MPLN Rankings

MPLN Latest News

MPLN Stock Data

111.74M
8.29M
7.7%
81.53%
1.4%
Health Information Services
Services-business Services, Nec
Link
United States of America
NEW YORK